Adage Capital Partners’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.45M | Sell |
185,000
-4,000
| -2% | -$74.5K | 0.01% | 735 |
|
|
2025
Q1 | $3.43M | Buy |
189,000
+9,000
| +5% | +$163K | 0.01% | 730 |
|
|
2024
Q4 | $3.92M | Buy |
+180,000
| New | +$3.92M | 0.01% | 738 |
|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$6.47M | – | 893 |
|
|
2024
Q2 | $6.47M | Sell |
250,000
-48,000
| -16% | -$1.24M | 0.01% | 680 |
|
|
2024
Q1 | $8.94M | Buy |
+298,000
| New | +$8.94M | 0.02% | 619 |
|
|
2023
Q1 | – | Sell |
-54,291
| Closed | -$343K | – | 937 |
|
|
2022
Q4 | $343K | Buy |
54,291
+3,125
| +6% | +$19.8K | ﹤0.01% | 869 |
|
|
2022
Q3 | $1.15M | Buy |
51,166
+7,044
| +16% | +$159K | ﹤0.01% | 885 |
|
|
2022
Q2 | $847K | Buy |
44,122
+19,879
| +82% | +$382K | ﹤0.01% | 929 |
|
|
2022
Q1 | $1.13M | Buy |
+24,243
| New | +$1.13M | ﹤0.01% | 931 |
|